Capital World Investors Qiagen N.V. Transaction History

Capital World Investors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$45.29 - $50.76 $50.6 Million - $56.7 Million	-1,117,772 Reduced 30.42%	2,557,053 $117 Million
Q3 2022 Nov 14, 2022	BUY	$40.9 - $50.42 $3,762 - $4,638	92 Added 0.0%	3,674,825 $152 Million
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $84.3 Million - $97.6 Million	-1,961,915 Reduced 34.81%	3,674,733 $173 Million
Q1 2022 May 16, 2022	SELL	$42.23 - $54.3 $35.1 Million - $45.2 Million	-832,118 Reduced 12.86%	5,636,648 $276 Million
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $14.5 Million - $17.7 Million	311,414 Added 5.06%	6,468,766 $334 Million

Q2 2021 Aug 16, 2021	SELL	$46.28 - $52.75 $28,415 - $32,388	-614 Reduced 0.01%	6,157,352 $298 Million
Q1 2021 May 14, 2021	BUY	$46.25 - $56.02 $285 Million - $345 Million	6,157,966 New	6,157,966 $300 Million
Q4 2018 Feb 14, 2019	SELL	$32.65 - $37.95 $71 Million - $82.6 Million	-2,176,056 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$35.99 - $39.39 $78.3 Million - $85.7 Million	2,176,056 New	2,176,056 $82.4 Million

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.16B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.